Table 1.
β-HPVa |
γ-HPVa |
|||||
---|---|---|---|---|---|---|
any | >1 | Unadjusted | any | >1 | Unadjusted | |
β-HPV | β-HPVb | OR | γ-HPV | γ-HPVb | OR | |
HIV status (%) | ||||||
HIV- | 71/354 | 15/71 | ref | 38/354 | 8/38 | ref |
(20.1) | (21.1) | (10.7) | (21.1) | |||
HIV+ | 23/31 | 13/23 | 11.46 | 15/31 | 2/15 | 7.80 |
(74.2) | (56.5) | (4.92–26.69) | (48.4) | (13.3) | (3.57–17.02) | |
Total number (%) | ||||||
94/385 | 28/94 | 53/385 | 10/53 | |||
(24.4) | (29.8) | (13.8) | (18.9) |
HIV-: HIV-negative; HIV+: HIV-positive
Includes participants who had at least one interpretable (β-globin positive) anal sample for any of the two HPV genus types tested (β-HPVs, and γ-HPVs)
Among participants who tested positive for that genera of HPV